Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Biotech Firm Seeks Corn Lily Supplies

by Michael McCoy
June 27, 2011 | A version of this story appeared in Volume 89, Issue 26

[+]Enlarge
Credit: Infinity Pharmaceuticals
Infinity Pharmaceuticals is seeking new sources of a plant commonly known as corn lily. Found on hills and alpine meadows across the western U.S., corn lily contains a key starting material for IPI-926, an Infinity investigational therapy that targets difficult-to-treat cancers such as pancreatic cancer and chondrosarcoma. Infinity has been obtaining corn lily from the U.S. Forest Service and several private landowners but is now reaching out to other landowners as it advances the study and clinical development of IPI-926.
Credit: Infinity Pharmaceuticals

Infinity Pharmaceuticals is seeking new sources of a plant commonly known as corn lily. Found on hills and alpine meadows across the western U.S., corn lily contains a key starting material for IPI-926, an Infinity investigational therapy that targets difficult-to-treat cancers such as pancreatic cancer and chondrosarcoma. Infinity has been obtaining corn lily from the U.S. Forest Service and several private landowners but is now reaching out to other landowners as it advances the study and clinical development of IPI-926.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.